版本:
中国

BRIEF-Champions Oncology posts Q3 adj. loss per share $0.11

March 16 Champions Biotechnology Inc

* Champions Oncology reports 40 pct revenue growth

* Q3 revenue rose 39.7 percent to $3.6 million

* For Q3 of fiscal 2017, champions reported a loss from operations of $1.4 million

* Qtrly non-GAAP loss per share $ 0.11

* Qtrly GAAP loss per share $0.13

* Qtrly non-GAAP loss per share $0.11

* Champions Biotechnology Inc - company ended quarter with $3.5 million of cash and cash equivalents on balance sheet Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐